What ReMedys does – Who we are...

Founders & Management Team

The ReMedys’ team consists of pharmaceutical industry professionals. The team monitors program deliverables, timelines and oversees the general development of projects and the foundation.

Dr. Michel Dreano

ReMedys Founder and Board Member

Dr. Dreano graduated from the University of Burgundy (PhD in Cell Biology) and from the University Paris 7/Institute Pasteur, France (PhD in Microbiology). He brings to the ReMedys more than 25 years professional experience in biotechnology and pharmaceuticals industry.

He recently established M3DC an independent consulting company. He has actively participated in the development of various drug candidates (small molecules and biologics) that have progressed up to clinical evaluation. These achievements were conducted in collaborations with renowned researchers worldwide in a number of therapeutic fields including neurology, oncology, endocrinology, arthritis, and nanotechnology. His work has led to the publication of numerous peer-reviewed articles and 10 patent families. Dr. Dreano is also the co-founder of Relief Therapeutics S.A. and has his own consulting company M3DC Sàrl. Dr. Dreano is specializing in the planning and execution of global multi-partner alliances involving industrial and academic partners for preclinical and clinical projects. This includes management of budget, timelines, resource allocation, follow up and reporting, thus securing professional management for ReMedys’ drug development project portfolio.

The  Foundation also has networks with professionals in the fields of animal safety/toxicology, regulatory affairs, drug metabolism/ pharmacokinetics, human pharmacology, manufacturing, clinical trial design, statistics, clinical research, clinical trial management, safety, business development, and project management.  Making these experts available as needed to projects ensures state-of-the-art development and increases the likelihood of success.